Skip to content
IPOandMore
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD ReviewNCD Analysis & Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search
Menu Close
  • Home
  • IPO/OFS/Stocks
    • IPO Review
    • Post IPO Analysis
    • Stock Analysis
  • Buybacks / Spl Situations
    • Recent Buybacks (Last 50)
    • All BuyBacks
    • Buyback Review
    • Special Situations
  • NCDs / Fixed Income
    • Fixed Income
    • NCD Review
  • Mutual Funds
  • Personal Finance
  • NRI
  • About
  • Toggle website search

Rossari Biotech

  1. Home>
  2. Rossari Biotech

Rossari Biotech IPO: Consoidated Brokerage Views

  • Post author:[email protected]
  • Post published:July 13, 2020
  • Post category:IPO Review
  • Post comments:0 Comments

This post on Rossari Biotech IPO tries to bring out consolidated brokerage views , subscription information, Grey Market Premium (GMP) and anchor investor information where applicable. The information collated from…

Continue ReadingRossari Biotech IPO: Consoidated Brokerage Views

Rossari Biotech IPO Review: in Fast lane

  • Post author:[email protected]
  • Post published:July 9, 2020
  • Post category:IPO Review
  • Post comments:0 Comments

Rossari Biotech IPO is slated to open on July 13 in the price band of Rs 423-425 per share. Rossari Biotec IPO entails rasing about Rs. 496.25 crore by means of…

Continue ReadingRossari Biotech IPO Review: in Fast lane

Archives

Categories

Copyright - WordPress Theme by OceanWP